| Serial Number | 79313063 |
| Word Mark | FKB |
| Filing Date | Monday, May 10, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 9, 2022 |
| Registration Number | 6810852 |
| Registration Date | Tuesday, August 9, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 24, 2022 |
| Goods and Services | Custom manufacture of pharmaceuticals |
| Goods and Services | Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases; pharmaceutical preparations for use in connection with humans for the treatment of parasitic diseases; pharmaceutical preparations for use in connection with humans for the prevention of parasitic diseases; pharmaceutical preparations for use in connection with humans for the treatment of neoplasms; pharmaceutical preparations for use in connection with humans for the prevention of neoplasms; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the blood; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the blood; pharmaceutical preparations for use in connection with humans for the treatment of diseases of blood-forming organs; pharmaceutical preparations for use in connection with humans for the prevention of diseases of blood-forming organs; pharmaceutical preparations for use in connection with humans for the treatment of diseases of certain disorders involving the immune mechanism; pharmaceutical preparations for use in connection with humans for the prevention of diseases of certain disorders involving the immune mechanism; pharmaceutical preparations for use in connection with humans for the treatment of endocrine diseases; pharmaceutical preparations for use in connection with humans for the prevention of endocrine diseases; pharmaceutical preparations for use in connection with humans for the treatment of nutritional diseases; pharmaceutical preparations for use in connection with humans for the prevention of nutritional diseases; pharmaceutical preparations for use in connection with humans for the treatment of metabolic diseases; pharmaceutical preparations for use in connection with humans for the prevention of metabolic diseases; pharmaceutical preparations for use in connection with humans for the treatment of mental disorders; pharmaceutical preparations for use in connection with humans for the prevention of mental disorders; pharmaceutical preparations for use in connection with humans for the treatment of behavioural disorders; pharmaceutical preparations for use in connection with humans for the prevention of behavioural disorders; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the nervous system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the nervous system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the eye; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the eye; pharmaceutical preparations for use in connection with humans for the treatment of diseases of eye adnexa; pharmaceutical preparations for use in connection with humans for the prevention of diseases of eye adnexa; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the ear; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the ear; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the mastoid process; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the mastoid process; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the circulatory system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the circulatory system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the respiratory system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the respiratory system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the digestive system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the digestive system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the skin; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the skin; pharmaceutical preparations for use in connection with humans for the treatment of diseases of subcutaneous tissue; pharmaceutical preparations for use in connection with humans for the prevention of diseases of subcutaneous tissue; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the musculoskeletal system pharmaceutical preparations for use in connection with humans for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the connective tissue; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the connective tissue; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the genitourinary system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the genitourinary system; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases and diabetes occurred in pregnancy; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases and diabetes occurred in pregnancy; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in childbirth; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in childbirth; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in the puerperium; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in the puerperium; pharmaceutical preparations for use in connection with humans for the treatment of nutritional deficiency conditions originating in the perinatal period; pharmaceutical preparations for use in connection with humans for the prevention of nutritional deficiency conditions originating in the perinatal period; pharmaceutical preparations for use in connection with humans for the treatment of congenital malformations; pharmaceutical preparations for use in connection with humans for the prevention of congenital malformations; pharmaceutical preparations for use in connection with humans for the treatment of deformations; pharmaceutical preparations for use in connection with humans for the prevention of deformations; pharmaceutical preparations for use in connection with humans for the treatment of chromosomal abnormalities; pharmaceutical preparations for use in connection with humans for the prevention of chromosomal abnormalities; prescribed pharmaceutical preparations for the treatment of infectious diseases; prescribed pharmaceutical preparations for the prevention of infectious diseases; prescribed pharmaceutical preparations for the treatment of parasitic diseases; prescribed pharmaceutical preparations for the prevention of parasitic diseases; prescribed pharmaceutical preparations for the treatment of neoplasms; prescribed pharmaceutical preparations for the prevention of neoplasms; prescribed pharmaceutical preparations for the treatment of diseases of the blood; prescribed pharmaceutical preparations for the prevention of diseases of the blood prescribed pharmaceutical preparations for the treatment of diseases of blood-forming organs; prescribed pharmaceutical preparations for the prevention of diseases of blood-forming organs; prescribed pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; prescribed pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; prescribed pharmaceutical preparations for the treatment of endocrine diseases; prescribed pharmaceutical preparations for the prevention of endocrine diseases; prescribed pharmaceutical preparations for the treatment of nutritional diseases; prescribed pharmaceutical preparations for the prevention of nutritional diseases; prescribed pharmaceutical preparations for the treatment of metabolic diseases; prescribed pharmaceutical preparations for the prevention of metabolic diseases; prescribed pharmaceutical preparations for the treatment of mental disorders; prescribed pharmaceutical preparations for the prevention of mental disorders; prescribed pharmaceutical preparations for the treatment of behavioural disorders; prescribed pharmaceutical preparations for the prevention of behavioural disorders; prescribed pharmaceutical preparations for the treatment of diseases of the nervous system; prescribed pharmaceutical preparations for the prevention of diseases of the nervous system; prescribed pharmaceutical preparations for the treatment of diseases of the eye; prescribed pharmaceutical preparations for the prevention of diseases of the eye; prescribed pharmaceutical preparations for the treatment of diseases of eye adnexa; prescribed pharmaceutical preparations for the prevention of diseases of eye adnexa; prescribed pharmaceutical preparations for the treatment of diseases of the ear; prescribed pharmaceutical preparations for the prevention of diseases of the ear; prescribed pharmaceutical preparations for the treatment of diseases of the mastoid process; prescribed pharmaceutical preparations for the prevention of diseases of the mastoid process; prescribed pharmaceutical preparations for the treatment of diseases of the circulatory system; prescribed pharmaceutical preparations for the prevention of diseases of the circulatory system; prescribed pharmaceutical preparations for the treatment of diseases of the respiratory system; prescribed pharmaceutical preparations for the prevention of diseases of the respiratory system; prescribed pharmaceutical preparations for the treatment of diseases of the digestive system; prescribed pharmaceutical preparations for the prevention of diseases of the digestive system; prescribed pharmaceutical preparations for the treatment of diseases of the skin; prescribed pharmaceutical preparations for the prevention of diseases of the skin; prescribed pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; prescribed pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; prescribed pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; prescribed pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; prescribed pharmaceutical preparations for the treatment of diseases of the connective tissue; prescribed pharmaceutical preparations for the prevention of diseases of the connective tissue; prescribed pharmaceutical preparations for the treatment of diseases of the genitourinary system; prescribed pharmaceutical preparations for the prevention of diseases of the genitourinary system; prescribed pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; prescribed pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; prescribed pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; prescribed pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; prescribed pharmaceutical preparations for the treatment of congenital malformations; prescribed pharmaceutical preparations for the prevention of congenital malformations; prescribed pharmaceutical preparations for the treatment of deformations; prescribed pharmaceutical preparations for the prevention of deformations; prescribed pharmaceutical preparations for the treatment of chromosomal abnormalities; prescribed pharmaceutical preparations for the prevention of chromosomal abnormalities; biological pharmaceutical preparations for the treatment of infectious diseases; biological pharmaceutical preparations for the prevention of infectious diseases; biological pharmaceutical preparations for the treatment of parasitic diseases; biological pharmaceutical preparations for the prevention of parasitic diseases; biological pharmaceutical preparations for the treatment of neoplasms; biological pharmaceutical preparations for the prevention of neoplasms; biological pharmaceutical preparations for the treatment of diseases of the blood; biological pharmaceutical preparations for the prevention of diseases of the blood; biological pharmaceutical preparations for the treatment of diseases of blood-forming organs; biological pharmaceutical preparations for the prevention of diseases of blood-forming organs; biological pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; biological pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; biological pharmaceutical preparations for the treatment of endocrine diseases; biological pharmaceutical preparations for the prevention of endocrine diseases; biological pharmaceutical preparations for the treatment of nutritional diseases; biological pharmaceutical preparations for the prevention of nutritional diseases; biological pharmaceutical preparations for the treatment of metabolic diseases; biological pharmaceutical preparations for the prevention of metabolic diseases; biological pharmaceutical preparations for the treatment of mental disorders; biological pharmaceutical preparations for the prevention of mental disorders; biological pharmaceutical preparations for the treatment of behavioural disorders; biological pharmaceutical preparations for the prevention of behavioural disorders; biological pharmaceutical preparations for the treatment of diseases of the nervous system; biological pharmaceutical preparations for the prevention of diseases of the nervous system; biological pharmaceutical preparations for the treatment of diseases of the eye; biological pharmaceutical preparations for the prevention of diseases of the eye; biological pharmaceutical preparations for the treatment of diseases of eye adnexa; biological pharmaceutical preparations for the prevention of diseases of eye adnexa; biological pharmaceutical preparations for the treatment of diseases of the ear; biological pharmaceutical preparations for the prevention of diseases of the ear; biological pharmaceutical preparations for the treatment of diseases of the mastoid process; biological pharmaceutical preparations for the prevention of diseases of the mastoid process; biological pharmaceutical preparations for the treatment of diseases of the circulatory system; biological pharmaceutical preparations for the prevention of diseases of the circulatory system; biological pharmaceutical preparations for the treatment of diseases of the respiratory system; biological pharmaceutical preparations for the prevention of diseases of the respiratory system; biological pharmaceutical preparations for the treatment of diseases of the digestive system; biological pharmaceutical preparations for the prevention of diseases of the digestive system; biological pharmaceutical preparations for the treatment of diseases of the skin; biological pharmaceutical preparations for the prevention of diseases of the skin; biological pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; biological pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; biological pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; biological pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; biological pharmaceutical preparations for the treatment of diseases of the connective tissue; biological pharmaceutical preparations for the prevention of diseases of the connective tissue; biological pharmaceutical preparations for the treatment of diseases of the genitourinary system; biological pharmaceutical preparations for the prevention of diseases of the genitourinary system; biological pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; biological pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; biological pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; biological pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; biological pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; biological pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; biological pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; biological pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; biological pharmaceutical preparations for the treatment of congenital malformations; biological pharmaceutical preparations for the prevention of congenital malformations; biological pharmaceutical preparations for the treatment of deformations; biological pharmaceutical preparations for the prevention of deformations; biological pharmaceutical preparations for the treatment of chromosomal abnormalities; biological pharmaceutical preparations for the prevention of chromosomal abnormalities; bandages for dressings |
| Pseudo Mark | FUJIFILM KYOWA KIRIN BIOLOGICS |
| Goods and Services | Providing information concerning commercial sales in the field of pharmaceuticals |
| Goods and Services | Pharmaceutical information services provided via the Internet, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services provided via the Internet; providing medical information |
| Goods and Services | Apparatus for drug administration, namely, drug delivery systems, comprised of injector, and autoinjector, both sold empty; therapeutic inhalers, sold empty; high frequency electromagnetic therapy apparatus; oxygen inhalers for therapeutic purposes sold empty; ultraviolet radiator units for therapeutic purposes; defibrillators; pneumothorax apparatus, namely, medical apparatus for diagnosing or treating respiratory conditions; heart pacemakers; mercury arc lamp units for therapeutic purposes; infrared radiator units for therapeutic purposes; puncture apparatus for therapeutic purposes, namely, medical devices for closing wounds; lavage apparatus for therapeutic purposes, namely, apparatus for washing out body cavities; carbon arc lamp units for therapeutic purposes; injection syringes, syringe barrels; injection needles; infusion apparatus for therapeutic purposes, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over rime; ultrasonic therapy machines and apparatus; short wave therapy machines and apparatus; therapeutic bath apparatus and instruments, namely, appliances for washing body cavities; massage apparatus for medical purposes; low frequency electric therapy apparatus; static electric therapy apparatus; dialyzers, namely, blood component separation apparatus for medical purposes; acupuncture needles; sprayers for medical purposes, namely, drug delivery sprayers sold empty; suture apparatus for medical purposes, namely, suture needles and suture materials; radioisotope therapy apparatus and instruments; incubators for babies; blood transfusion apparatus; containers and trays specially designed for transporting and holding pharmaceuticals; injection device for pharmaceuticals; injection instruments without needles; injection instruments with needles |
| Goods and Services | Pharmaceutical research; pharmaceutical development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 25, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 25, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 25, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 25, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 25, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 25, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Friday, October 6, 2023 | INTERNATIONAL REGISTRATION RENEWED |
| Sunday, January 15, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, November 18, 2022 | GENERIC MADRID TRANSACTION SENT TO IB |
| Friday, November 18, 2022 | GENERIC MADRID TRANSACTION CREATED |
| Wednesday, November 9, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 9, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 9, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Monday, May 30, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, May 24, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 24, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 4, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, May 4, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, May 4, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, April 18, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 18, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 18, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 18, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 21, 2022 | REFUSAL PROCESSED BY IB |
| Wednesday, February 23, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, February 23, 2022 | REFUSAL PROCESSED BY MPU |
| Saturday, January 29, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, January 28, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, January 14, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, June 29, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, June 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, June 21, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, June 11, 2021 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |